Table 2 The five highest ranking items per question in the phase two evaluation survey
From: Evaluation of the Australian first few X household transmission project for COVID-19
Evaluation question | Themes identified | Weighted scorea |
|---|---|---|
What worked well with the FFX project and why? | 1. Timely analysis and reporting | 26 |
2. Central coordination by APPRISE | 24 | |
3. Specific models of implementation at each site | 23 | |
4. National funding mechanism and support | 21 | |
5. Collaboration with researchers/research organisations | 19 | |
What didn’t work well with the FFX project and why? | 1. Length and complexity of ethics and governance approval processes | 23 |
2. Missed opportunity due to delayed start of implementation | 22 | |
3. Missed opportunities due to lack of active engagement from health departments | 20 | |
4. Differing ethical and legislative frameworks across jurisdictions | 20 | |
5. Division into public health and research components led to lost opportunities | 17 | |
What expectations did you have for the FFX project? | 1. The project would deliver on classic FFX objectives and would provide early and rapid epidemiological insights | 34 |
2. Able to deliver local information on key knowledge gaps | 20 | |
3. There would be more and faster recruitment | 18 | |
4. The data would play a larger role to inform public health advice | 16 | |
A. Relevance of original objectives/research questions waned over time | 10 | |
B. That data would be more accessible and shared in a timely manner | 10 | |
What value do you expect FFX to provide in the ongoing/future FFX study? | 1. Opportunity to conduct further multijurisdictional FFX or related research studies in Australia | 25 |
2. Further develop surveillance systems and capacity at a national level for pandemic response | 21 | |
3. Developing a process for expedited ethics and governance approvals for future iterations | 19 | |
4. Establishment of a research network within existing public health systems | 19 | |
5. Opportunity to characterise impacts of immunity and vaccination on severity and transmissibility within households | 15 | |
What are the key foundational components/arrangements to have prepared for next time? | 1. Pre-established ethics and governance mechanisms/approvals that cover all study aspects | 31 |
2. Investments in national data infrastructure to assist with rapid data sharing | 16 | |
3. Clarification of role of FFX studies in national and jurisdictional surveillance plans for pandemic response | 15 | |
4. Maintenance of existing data governance and sharing arrangements from current project | 12 | |
5. Embed within public health work to avoid duplication and participant confusion | 10 |